Cherry SE Reports Changes in Revenue and EBITDA; Secures Financial Support

Munich, October 19, 2026 – Cherry SE's financial performance for the first nine months of 2026 shows a deviation from the previous year. Preliminary data indicates an adjusted Group EBITDA of EUR -6.9 million, improving from EUR -11.9 million in the same period of 2025, mainly due to an increased gross margin by 7.4 percentage points. The company attributes this positive change to cost reductions stemming from project Blossom.

However, group revenue decreased to EUR 58.9 million from EUR 70.7 million, largely due to actions in the Peripherals segment aimed at clearing distribution inventories. The figures include the Digital Health segment, earmarked for sale in a current M&A process.

Cherry SE also announced an agreement with Cherry TopCo S.à r.l., securing up to EUR 5 million in financial support from Argand Partners, which will remain effective until December 31, 2026.